North America Drug Safety Solutions and Pharmacovigilance Market – Industry Trends and Forecast to 2026

1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY

1.2 MARKET DEFINITION

1.3 OVERVIEW OF NORTH AMERICA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET

1.4 LIMITATIONS

1.5 MARKETS COVERED

2 MARKET SEGMENTATION

2.1 MARKETS COVERED

2.2 GEOGRAPHICAL SCOPE

2.3 YEARS CONSIDERED FOR THE STUDY YEARS CONSIDERED FOR THE STUDY

2.4 CURRENCY AND PRICING

2.5 DBMR TRIPOD DATA VALIDATION MODEL

2.6 MULTIVARIATE MODELLING

2.7 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.8 DBMR MARKET POSITION GRID

2.9 VENDOR SHARE ANALYSIS

2.10 SECONDARY SOURCES

2.11 ASSUMPTIONS

3 MARKET OVERVIEW

3.1 DRIVERS

3.1.1 INCREASING NUMBER OF CLINICAL TRIALS

3.1.2 GROWING NUMBER OF CONTRACT RESEARCH ORGANIZATIONS

3.1.3 INCREASE IN R & D EXPENDITURE BY PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES

3.1.4 INCREASE IN THE NUMBER OF ADVERSE DRUG REACTIONS (ADRS)

3.2 RESTRAINT

3.2.1 HIGH COST OF DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE

3.3 OPPORTUNITIES

3.3.1 AUTOMATION IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE

3.3.2 RESEARCH COLLABORATIONS AND PARTNERSHIPS

3.3.3 STRATEGIC INITIATIVES BY MARKET PLAYERS

3.4 CHALLENGE

3.4.1 THE MISREPORTING AND MISCODING OF ADVERSE EVENTS

4 EXECUTIVE SUMMARY

5 NORTH AMERICA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY TYPE

5.1 OVERVIEW

5.2 SOFTWARE

5.2.1 ADVERSE EVENT REPORTING SOFTWARE

5.2.1.1 ON-PREMISE

5.2.1.2 CLOUD BASED

5.2.2 DRUG SAFETY AUDITS SOFTWARE

5.2.2.1 ON-PREMISE

5.2.2.2 CLOUD BASED

5.2.3 DATA MANAGEMENT SOFTWARE

5.2.3.1 ON-PREMISE

5.2.3.2 CLOUD BASED

5.2.4 FULLY INTEGRATED SOFTWARE

5.2.4.1 ON-PREMISE

5.2.4.2 CLOUD BASED

5.2.5 ISSUE TRACKING SOFTWARE

5.2.5.1 ON-PREMISE

5.2.5.2 CLOUD BASED

5.2.6 CLINICAL TRIAL MANAGEMENT SOLUTION

5.2.6.1 ON-PREMISE

5.2.6.2 CLOUD BASED

5.2.7 REGULATORY CONTENT AND INFORMATION MANAGEMENT SOFTWARE

5.2.7.1 ON-PREMISE

5.2.7.2 CLOUD BASED

5.2.8 MEDICAL AFFAIRS SOFTWARE

5.2.8.1 ON-PREMISE

5.2.8.2 CLOUD BASED

5.2.9 OTHERS

5.2.9.1 ON-PREMISE

5.2.9.2 CLOUD BASED

5.3 SERVICES

5.3.1 CLINICAL DATA MANAGEMENT

5.3.1.1 DATA ENTRY AND CASE PROCESSING

5.3.1.2 CLINICAL TRIAL MONITORING

5.3.1.3 CLINICAL TRIAL SAFETY SUBMISSIONS

5.3.1.4 CASE PROCESSING (SAES)

5.3.1.5 OTHERS

5.3.2 DRUG SAFETY SOLUTIONS

5.3.2.1 QUALITY AND MEDICAL REVIEW

5.3.2.2 LITERATURE AND SOCIAL MEDIA MONITORING

5.3.2.3 SAFETY DATABASE

5.3.2.4 INDIVIDUAL CASE STUDY REPORT

5.3.2.5 PERIODIC REPORTS

5.3.2.6 MEDICAL LITERATURE SEARCH

5.3.2.7 SIGNAL DETECTION

5.3.2.8 EXPEDITED REPORTS

5.3.2.9 OTHERS

5.3.3 AGGREGATE SAFETY REPORTING

5.3.4 REGULATORY SERVICES

5.3.4.1 SAFETY REGULATORY SUBMISSIONS

5.3.4.2 POST-MARKETING SURVEILLANCE

5.3.4.3 MEDICAL DEVICE VIGILANCE

5.3.4.4 REGULATORY CONSULTING

5.3.4.5 OTHERS

5.3.5 RISK MANAGEMENT SERVICES

5.3.6 MEDICAL INFORMATION CALL CENTER SERVICES

5.3.7 AUDIT SERVICES

5.3.8 TRAINING SUPPORT SERVICES

5.3.9 OTHERS

6 NORTH AMERICA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY END USERS

6.1 OVERVIEW

6.2 PHARMACEUTICAL & BIOTECHNOLOGY INDUSTRIES

6.3 CONTRACT RESEARCH ORGANIZATIONS (CROS)

6.4 HOSPITALS

6.5 KPOS/BPOS

6.6 HEALTHCARE PROVIDERS

6.7 OTHERS

7 NORTH AMERICA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY DISTRIBUTION CHANNEL

7.1 OVERVIEW

7.2 DIRECT SALES

7.3 RETAIL SALES

8 NORTH AMERICA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY GEOGRAPHY

8.1 NORTH AMERICA

8.1.1 U.S.

8.1.2 CANADA

8.1.3 MEXICO

9 NORTH AMERICA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, COMPANY LANDSCAPE

9.1 COMPANY SHARE ANALYSIS: NORTH AMERICA

10 COMPANY PROFILE

10.1 SYNEOS HEALTH

10.1.1 COMPANY SNAPSHOT

10.1.2 REVENUE ANALYSIS

10.1.3 COMPANY SHARE ANALYSIS

10.1.4 SOLUTION PORTFOLIO

10.1.5 RECENT DEVELOPMENT

10.2 COVANCE INC. (A SUBSIDIARY OF LABCORP)

10.2.1 COMPANY SNAPSHOT

10.2.2 REVENUE ANALYSIS

10.2.3 COMPANY SHARE ANALYSIS

10.2.4 SERVICE PORTFOLIO

10.2.5 RECENT DEVELOPMENTS

10.3 COGNIZANT

10.3.1 COMPANY SNAPSHOT

10.3.2 REVENUE ANALYSIS

10.3.3 COMPANY SHARE ANALYSIS

10.3.4 SOLUTION PORTFOLIO

10.3.5 RECENT DEVELOPMENT

10.4 ACCENTURE

10.4.1 COMPANY SNAPSHOT

10.4.2 REVENUE ANALYSIS

10.4.3 COMPANY SHARE ANALYSIS

10.4.4 SERVICE PORTFOLIO

10.4.5 RECENT DEVELOPMENTS

10.5 PAREXEL INTERNATIONAL CORPORATION

10.5.1 COMPANY SNAPSHOT

10.5.2 PRODUCT PORTFOLIO

10.5.3 RECENT DEVELOPMENTS

10.6 ORACLE

10.6.1 COMPANY SNAPSHOT

10.6.2 REVENUE ANALYSIS

10.6.3 SOLUTION PORTFOLIO

10.6.4 RECENT DEVELOPMENT

10.7 AB CUBE

10.7.1 COMPANY SNAPSHOT

10.7.2 SOLUTION PORTFOLIO

10.7.3 RECENT DEVELOPMENT

10.8 ARISNORTH AMERICA

10.8.1 COMPANY SNAPSHOT

10.8.2 PRODUCT PORTFOLIO

10.8.3 RECENT DEVELOPMENTS

10.9 BIOCLINICA

10.9.1 COMPANY SNAPSHOT

10.9.2 SERVICE PORTFOLIO

10.9.3 RECENT DEVELOPMENTS

10.10 C3I

10.10.1 COMPANY SNAPSHOT

10.10.2 REVENUE ANALYSIS

10.10.3 SERVICE PORTFOLIO

10.10.4 RECENT DEVELOPMENTS

10.11 DRUG SAFETY SOLUTIONS LIMITED

10.11.1 COMPANY SNAPSHOT

10.11.2 SERVICE PORTFOLIO

10.11.3 RECENT DEVELOPMENT

10.12 ENNOV

10.12.1 COMPANY SNAPSHOT

10.12.2 PRODUCT PORTFOLIO

10.12.3 RECENT DEVELOPMENTS

10.13 ERGOMED PLC

10.13.1 COMPANY SNAPSHOT

10.13.2 REVENUE ANALYSIS

10.13.3 SERVICE PORTFOLIO

10.13.4 RECENT DEVELOPMENTS

10.14 GENPACT

10.14.1 COMPANY SNAPSHOT

10.14.2 REVENUE ANALYSIS

10.14.3 PRODUCT PORTFOLIO

10.14.4 RECENT DEVELOPMENTS

10.15 ICON PLC

10.15.1 COMPANY SNAPSHOT

10.15.2 REVENUE ANALYSIS

10.15.3 SERVICE PORTFOLIO

10.15.4 RECENT DEVELOPMENTS

10.16 IQVIA

10.16.1 COMPANY SNAPSHOT

10.16.2 REVENUE ANALYSIS

10.16.3 SOLUTION PORTFOLIO

10.16.4 RECENT DEVELOPMENTS

10.17 PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC.

10.17.1 COMPANY SNAPSHOT

10.17.2 SERVICE PORTFOLIO

10.17.3 RECENT DEVELOPMENTS

10.18 PHARMACEUTICAL RESEARCH ASSOCIATES INC.

10.18.1 COMPANY SNAPSHOT

10.18.2 REVENUE ANALYSIS

10.18.3 SOLUTION PORTFOLIO

10.18.4 RECENT DEVELOPMENTS

10.19 UNITED BIOSOURCE LLC

10.19.1 COMPANY SNAPSHOT

10.19.2 SERVICE PORTFOLIO

10.19.3 RECENT DEVELOPMENT

10.20 WORLDWIDE CLINICAL TRIALS

10.20.1 COMPANY SNAPSHOT

10.20.2 SERVICE PORTFOLIO

10.20.3 RECENT DEVELOPMENTS

11 QUESTIONNAIRE

12 RELATED REPORTS

UU

TABLE 1 CLINICAL TRIAL CONDUCTED IN DIFFERENT LOCATIONS

TABLE 2 TOP 20 PHARMA COMPANIES BY SIZE OF PIPELINE

TABLE 3 NORTH AMERICA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 4 NORTH AMERICA SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 5 NORTH AMERICA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 6 NORTH AMERICA ADVERSE EVENT REPORTING SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 7 NORTH AMERICA ADVERSE EVENT REPORTING SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 8 NORTH AMERICA DRUG SAFETY AUDITS SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 9 NORTH AMERICA DRUG SAFETY AUDITS SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 10 NORTH AMERICA DATA MANAGEMENT SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 11 NORTH AMERICA DATA MANAGEMENT SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 12 NORTH AMERICA FULLY INTEGRATED SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 13 NORTH AMERICA FULLY INTEGRATED SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 14 NORTH AMERICA ISSUE TRACKING SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 15 NORTH AMERICA ISSUE TRACKING SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 16 NORTH AMERICA CLINICAL TRIAL MANAGEMENT SOLUTION IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 17 NORTH AMERICA CLINICAL TRIAL MANAGEMENT SOLUTION IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 18 NORTH AMERICA REGULATORY CONTENT AND INFORMATION MANAGEMENT SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 19 NORTH AMERICA REGULATORY CONTENT AND INFORMATION MANAGEMENT SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 20 NORTH AMERICA MEDICAL AFFAIRS SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 21 NORTH AMERICA MEDICAL AFFAIRS SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 22 NORTH AMERICA OTHERS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 23 NORTH AMERICA OTHERS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 24 NORTH AMERICA SERVICES IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 25 NORTH AMERICA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)

TABLE 26 NORTH AMERICA CLINICAL DATA MANAGEMENT IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)

TABLE 27 NORTH AMERICA DRUG SAFETY SOLUTIONS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)

TABLE 28 NORTH AMERICA REGULATORY SERVICES IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)

TABLE 29 NORTH AMERICA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE, BY END USER, 2017-2026 (USD MILLION)

TABLE 30 NORTH AMERICA PHARMACEUTICAL & BIOTECHNOLOGY IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 31 NORTH AMERICA CONTRACT RESEARCH ORGANIZATIONS (CROS) IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 32 NORTH AMERICA HOSPITALS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 33 NORTH AMERICA KPOS/BPOS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 34 NORTH AMERICA HEALTHCARE PROVIDERS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 35 NORTH AMERICA OTHERS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 36 NORTH AMERICA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 37 NORTH AMERICA DIRECT SALES IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 38 NORTH AMERICA RETAIL SALES IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 39 NORTH AMERICA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY REGION, 2017-2026 (USD MILLION)

TABLE 40 NORTH AMERICA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 41 NORTH AMERICA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 42 NORTH AMERICA ADVERSE EVENT REPORTING SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 43 NORTH AMERICA DRUG SAFETY AUDITS SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 44 NORTH AMERICA DATA MANAGEMENT SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 45 NORTH AMERICA FULLY INTEGRATED SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 46 NORTH AMERICA ISSUE TRACKING SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 47 NORTH AMERICA CLINICAL TRIAL MANAGEMENT SOLUTION IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 48 NORTH AMERICA REGULATORY CONTENT AND INFORMATION MANAGEMENT SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 49 NORTH AMERICA MEDICAL AFFAIRS SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 50 NORTH AMERICA OTHERS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 51 NORTH AMERICA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)

TABLE 52 NORTH AMERICA CLINICAL DATA MANAGEMENT IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)

TABLE 53 NORTH AMERICA DRUG SAFETY SOLUTIONS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)

TABLE 54 NORTH AMERICA REGULATORY SERVICES IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)

TABLE 55 NORTH AMERICA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 56 NORTH AMERICA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 57 U.S. DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 58 U.S. DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 59 U.S. ADVERSE EVENT REPORTING SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 60 U.S. DRUG SAFETY AUDITS SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 61 U.S. DATA MANAGEMENT SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 62 U.S. FULLY INTEGRATED SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 63 U.S. ISSUE TRACKING SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 64 U.S. CLINICAL TRIAL MANAGEMENT SOLUTION IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 65 U.S. REGULATORY CONTENT AND INFORMATION MANAGEMENT SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 66 U.S. MEDICAL AFFAIRS SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 67 U.S. OTHERS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 68 U.S. DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)

TABLE 69 U.S. CLINICAL DATA MANAGEMENT IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)

TABLE 70 U.S. DRUG SAFETY SOLUTIONS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)

TABLE 71 U.S. REGULATORY SERVICES IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)

TABLE 72 U.S. DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 73 U.S. DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 74 CANADA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 75 CANADA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 76 CANADA ADVERSE EVENT REPORTING SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 77 CANADA DRUG SAFETY AUDITS SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 78 CANADA DATA MANAGEMENT SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 79 CANADA FULLY INTEGRATED SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 80 CANADA ISSUE TRACKING SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 81 CANADA CLINICAL TRIAL MANAGEMENT SOLUTION IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 82 CANADA REGULATORY CONTENT AND INFORMATION MANAGEMENT SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 83 CANADA MEDICAL AFFAIRS SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 84 CANADA OTHERS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 85 CANADA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)

TABLE 86 CANADA CLINICAL DATA MANAGEMENT IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)

TABLE 87 CANADA DRUG SAFETY SOLUTIONS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)

TABLE 88 CANADA REGULATORY SERVICES IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)

TABLE 89 CANADA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 90 CANADA DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)

TABLE 91 MEXICO DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY TYPE, 2017-2026 (USD MILLION)

TABLE 92 MEXICO DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 93 MEXICO ADVERSE EVENT REPORTING SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 94 MEXICO DRUG SAFETY AUDITS SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 95 MEXICO DATA MANAGEMENT SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 96 MEXICO FULLY INTEGRATED SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 97 MEXICO ISSUE TRACKING SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 98 MEXICO CLINICAL TRIAL MANAGEMENT SOLUTION IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 99 MEXICO REGULATORY CONTENT AND INFORMATION MANAGEMENT SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 100 MEXICO MEDICAL AFFAIRS SOFTWARE IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 101 MEXICO OTHERS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SOFTWARE, 2017-2026 (USD MILLION)

TABLE 102 MEXICO DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)

TABLE 103 MEXICO CLINICAL DATA MANAGEMENT IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)

TABLE 104 MEXICO DRUG SAFETY SOLUTIONS IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)

TABLE 105 MEXICO REGULATORY SERVICES IN DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY SERVICES, 2017-2026 (USD MILLION)

TABLE 106 MEXICO DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY END USER, 2017-2026 (USD MILLION)

TABLE 107 MEXICO DRUG SAFETY SOLUTIONS & PHARMACOVIGILANCE MARKET, BY DISTRIBUTION CHANNEL, 2017-2026 (USD MILLION)